AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
AdaptHealth Corp.NASDAQ: AHCO
Gross Margin · Q1 FY2026 · quarter ended Apr 2026
Gross margin widens to 12.4%
Gross margin was 12.4% in Q1 FY2026, up 25.6 pp from a year earlier. On a trailing-twelve-month basis it was 5.4%, up 0.6 pp year over year. Over 3 fiscal years it widened by 3.5 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 17.5%
- Year-over-year change
- -3.4pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 17.5% | -3.4pp |
| FY2024 | 2024-12-31 | 20.9% | -0.4pp |
| FY2023 | 2023-12-31 | 21.3% | +7.3pp |
| FY2022 | 2022-12-31 | 14.1% | -4.1pp |
| FY2021 | 2021-12-31 | 18.2% | — |
Gross Margin vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's LTM Apr 2026 gross margin of 5.4% is the lowest of the 9 companies compared; the peer median is 57.2%.
- Its year-over-year change of +0.6 pp is the 8th highest of 9, against a peer median of +2.2 pp.
- Over three fiscal years its change of +3.5 pp compares with a peer median of +1.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 86.1% | +1.7 pp | +1.6 pp | |
| LTM Mar 2026 | 78.4% | +0.9 pp | +2.6 pp | |
| LTM Jun 2026 | 61.2% | +1.8 pp | +5.3 pp | |
| LTM Mar 2026 | 57.3% | -1.4 pp | -3.5 pp | |
| LTM Mar 2026 | 57.2% | +3.2 pp | -44.6 pp | |
| LTM Mar 2026 | 56.7% | +3.6 pp | +0.9 pp | |
| LTM Mar 2026 | 54.9% | +8.4 pp | +0.8 pp | |
| LTM Mar 2026 | 48.7% | +2.6 pp | +6.9 pp | |
| LTM Apr 2026 | 5.4% | +0.6 pp | +3.5 pp | |
| Peer median (excluding AHCO) | 57.2% | +2.2 pp | +1.2 pp | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.45B | 2.97B | 3.2B | 3.26B | 3.24B |
| Cost of Revenue | 2.01B | 2.55B | 2.52B | 2.58B | 2.68B |
| Gross Profit | 445.61M | 417.43M | 681.77M | 681.09M | 568.56M |
| Gross Margin | 18.2% | 14.1% | 21.3% | 20.9% | 17.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 167.51M | 162.13M | 190.09M | 359.24M | 382.29M |
| Operating Expenses | 220.01M | 227.02M | 1.28B | 417.36M | 382.29M |
| Depreciation & Amortization | 258.05M | 423.44M | 420.59M | 365.33M | 413.04M |
| EBITDA | 544.21M | 630.76M | (171.09M) | 628.02M | 503.64M |
| EBITDA Margin | 22.2% | 21.2% | -5.3% | 19.3% | 15.5% |
| Operating Income | 225.61M | 190.41M | (598.4M) | 263.73M | 186.27M |
| Operating Margin | 9.2% | 6.4% | -18.7% | 8.1% | 5.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.2M | 109.41M | 130.3M | 126.67M | 105.75M |
| Other Income / Expenses | (34.65M) | (92.51M) | (125.38M) | (127.71M) | (201.42M) |
| Income Before Tax | 190.96M | 97.9M | (723.78M) | 136.02M | (15.15M) |
| Pre-Tax Margin | 7.8% | 3.3% | -22.6% | 4.2% | -0.5% |
| Income Tax Expense | 32.81M | 24.77M | (49M) | 41.24M | 50.88M |
| Net Income | 156.18M | 69.32M | (678.9M) | 90.42M | (70.79M) |
| Net Margin | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
| EPS (Basic) | 1.12 | 0.52 | (5.32) | 0.62 | (0.52) |
| EPS (Diluted) | 0.67 | 0.50 | (5.31) | 0.61 | (0.52) |
| Weighted Avg Shares | 126.31M | 134.18M | 134.16M | 133.76M | 135.15M |
| Weighted Avg Shares (Diluted) | 133.03M | 138.99M | 134.42M | 135.53M | 135.15M |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.